Human Placentas and the Changing Face of Reproductive Toxicology Testing
DOI:
https://doi.org/10.17140/GOROJ-2-e004Keywords:
Placenta, Perfusion, Models, Reproductive, Toxicology, Testing, AnimalAbstract
Pharmaceuticals are in use by 40-98% of pregnant mothers in the developed world, varying by country. There is a significant potential for obstetricians to further maintain medical prescriptions for chronic diseases during pregnancy, provided there is confidence within the pharmaceutical industry on the safety of their products. The safety of medicinal products incurs several socioeconomic challenges, and the protection of maternal and fetal health is a foremost and top priority.
References
Burden N, Sewell F, Chapman K. Testing chemical safety: what is needed to ensure the widespread application of non-animal approaches? PLoSBiol. 2015; 13: e1002156. doi: 10.1371/journal.pbio.1002156
Willyard C. The boom in mini stomachs, brains, breasts, kidneys and more. Nature. 2015; 523: 520. doi: 10.1038/523520a
Reardon S. ‘Organs-on-chips’ go mainstream. Nature. 2015; 523: 266. doi: 10.1038/523266a
Esch EW, BahinskiA, Huh D. Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov. 2015; 14: 248-260. doi: 10.1038/nrd4539 Gynecol Obstet Res Open J Page e10
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Gynecology and Obstetrics Research (GOR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.